scispace - formally typeset
F

Fengchao Wang

Researcher at Bengbu Medical College

Publications -  6
Citations -  145

Fengchao Wang is an academic researcher from Bengbu Medical College. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 3 publications receiving 80 citations.

Papers
More filters
Journal ArticleDOI

Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel.

TL;DR: Results indicate that pac litaxel-induced expression of PDK2 serves as an important mechanism for acquired paclitaxel resistance of lung cancer cells, and highlight the importance ofPDK2 for potential therapeutic interventions in patients who have developed a resistance to paclitAXel.
Journal ArticleDOI

Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.

TL;DR: Observations show that PKM2 activates both glycolysis and lipid synthesis, thereby regulating cell proliferation and invasion, thereby providing the basic data required for the development of PKM 2-targeted gene therapy.
Journal ArticleDOI

TLR4 regulates RORγt+ regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila

TL;DR: In this paper , the influence of TLR4 on the shaping of intestinal microbiota and immune responses during colon inflammation remains poorly characterized, and the authors investigated whether the different susceptibilities to colitis between wild-type (WT) and TL-like receptor 4 −/− mice were gut microbiota-dependent and aimed to identify the potential immunity modulation mechanism.
Journal ArticleDOI

Meta-analysis of association between rs1447295 polymorphism and prostate cancer susceptibility

TL;DR: There are strong association between rs1447295 polymorphism and prostate cancer susceptibility in different ethnic groups and different prostate cancer stage, suggesting that rs 1447295 might serve as a reliable biomarker for prostate cancer diagnosis.
Journal ArticleDOI

Serum biomarker panel for disease severity and prognosis in patients with COVID‐19

TL;DR: In this article , the authors investigate the functions of inflammatory factors and serum markers that participate in disease progression and find that inflammatory factors have the potential to either enhance the efficiency of host immune responses or damage the host organs with immune overreaction in COVID-2019.